A new molecular imaging agent has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC).
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
SNMMI: PET imaging improves OMD detection in breast cancer patients
PET imaging improves oligometastatic breast cancer detection over conventional imaging.
-
SNMMI: F-18 FDS PET distinguishes molds in invasive fungal infections
Novel PET radiotracer shows promise for molecular imaging infection and inflammation.
-
When a Giant Scrotum Imitates a Germ Cell Tumour
Histology of the resected scrotal mass shows spindle-shaped cells, and immunohistochemistry confirms an angiomyofibroblastoma diagnosis. Medscape UK
-
Identifying critical moments of patient anxiety throughout the MRI care pathway: From prescription to results
As of 2022, France had 693 MRI scanners across 429 public and non-profit institutions, performing 3.1 million procedures, 81 % of which are outpatient. MRI is a non-invasive, painless imaging modality that does not expose patients to ionizing radiation [2]. However, it induces physiological and psychological stress [5], which can affect patients and their medical care. For example, patients have reported a better experience with contrast-enhanced spectral mammography than with contrast-enhanced …
-
Enhancing MRI efficiency in musculoskeletal examinations: Impact of optimized facility design and workflow optimization efforts
The rising demand for magnetic resonance imaging (MRI), combined with the modality’s inherent complexity, cost, and time-consuming nature, has posed significant challenges for healthcare systems worldwide. With growing MRI utilization globally [1,2] and the shift to value-based healthcare, imaging institutions must scrutinize all aspects of the MRI workflow to improve efficiency while maintaining high-quality patient care
-
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
-
SNMMI: Dual-targeting radioligand therapy safe for several cancers
A new “dual-targeting” radioligand therapy has been shown to be safe and effective in humans.
-
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
A video interview with Phillip Kuo, MD, PhD, on Alzheimer’s disease imaging.
-
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.